SBIR/STTR Research Award

DEVELOPMENT OF A RAPID IMMUNOASSAY FOR SYPHILIS

Award identifier f944e210ab89d716d9a5eacc02ab9004821e776c8cedde9dbd1389840949d3a1Awarding agency Department of Health and Human Services

Award amount

$45,675

Program and phase

SBIR · Phase I

Award year

1987

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Diamedix Corpon
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

SYPHILIS, STILL A MAJOR SERIOUS INFECTIOUS DISEASE, CAN BE TREATED EFFECTIVELY IF DIAGNOSED EARLY. THE NUMBER OF DEATHS FROM SYPHILIS IN THE UNITED STATES HAS SHOWN A STEADY DECREASE, BUT THE NUMBER OF SYPHILIS CASES HAS NOT SHOWN A SIGNIFICANT DROP. SEROLOGICAL TESTS PLAY A MAJOR ROLE IN THE DIAGNOSIS OF SYPHILIS. THESE TESTS MUST BE PERFORMED BY QUALIFIED TECHNICIANS IN A LABORATORY. THE PROPOSED PROJECT IS TO DEVELOP A RAPID, SIMPLE, RELIABLE, AND INEXPENSIVE IMMUNOASSAY SUITABLE FOR USE IN PHYSICIANS' OFFICES. ANTIGENS OF THE CAUSATIVE AGENT TREPONEMA PALLIDUM WILL BE COATED ONTO A FILTER PAPER AS A SMALL DOT. IN THE ASSAY, THE TEST SERUM SAMPLE, ENZYME-LABELED ANTIBODIES TO HUMAN IMMUNOGLOBULINS, AND SUBSTRATE ARE ADDED SEQUENTIALLY TO THE ANTIGEN DOT. NO INCUBATION IS REQUIRED, SINCE THE SAMPLE AND REAGENTS DIFFUSE RAPIDLY, CONTACTING AND REACTING INSTANTANEOUSLY WITH EACH OTHER IN THE FIBER MESH. THE RESULTS ARE READ VISUALLY, AND A BLUE DOT INDICATES A POSITIVE REACTION. THE RESEARCH WILL FOCUS ON: (1) SELECTION OF FILTER PAPERS THAT WILL GIVE A MAXIMUM COATING OF ANTIGENS BUT A MINIMUM NONSPECIFIC ADSORPTION OF SERUM AND REAGENTS; (2) BEST CONDITIONS (TEMPERATURE, TIME, BUFFER, AND CONCENTRATION) FOR COATING ANTIGENS; (3) POSTCOATING (MATERIALS AND CONDITIONS) TO MINIMIZE OR ELIMINATE BACKGROUND REACTIONS; AND (4) VOLUME AND CONCENTRATION OF SAMPLE AND REAGENTS. A REFINED ASSAY PROCEDURE WILL BE TESTED WITH A PANEL OF MORE THAN 200 CLINICAL SERUM SAMPLES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.